Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Runcaciguat in NPDR (NEON-NPDR)
NCT04722991Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of runcaciguat, sponsored by Bayer. Started Mar 2021; status: completed.
02
Drugs
runcaciguat
Beyond the preview
Go deeper on NCT04722991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04722991.